Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa.
IRCCS Neuromed, Pozzilli (IS).
Eur J Histochem. 2021 Jun 1;65(s1):3220. doi: 10.4081/ejh.2021.3220.
The interplay between autophagy (ATG) and ubiquitin proteasome (UP) cell-clearing systems was recently evidenced at biochemical and morphological levels, where subunits belonging to both pathways co-localize within a novel organelle named autophagoproteasome (APP). We previously documented that APP occurs at baseline conditions, while it is hindered by neurotoxicant administration. This is bound to the activity of the mechanistic target of rapamycin (mTOR), since APP is stimulated by mTOR inhibition, which in turn, is correlated with cell protection. In this brief report, we provide novel, morphological and biochemical evidence on APP, suggesting the presence of active UP subunits within ATG vacuoles. Although a stream of interpretation considers such a merging as a catabolic pathway to clear inactive UP subunits, our data further indicate that UP-ATG merging may rather provide an empowered catalytic organelle.
自噬(ATG)和泛素蛋白酶体(UP)细胞清除系统之间的相互作用最近在生化和形态学水平上得到了证实,两条途径的亚基在一种新的称为自噬蛋白酶体(APP)的细胞器内共定位。我们之前的研究记录到 APP 在基线条件下存在,而在神经毒性物质给药时受到抑制。这与雷帕霉素的作用机制靶点(mTOR)的活性有关,因为 APP 受到 mTOR 抑制的刺激,而 mTOR 抑制又与细胞保护相关。在本简要报告中,我们提供了 APP 的新的形态学和生化证据,表明在 ATG 空泡内存在活性的 UP 亚基。虽然有一种解释认为这种融合是一种清除无活性 UP 亚基的分解代谢途径,但我们的数据进一步表明,UP-ATG 的融合可能提供了一个功能强大的催化细胞器。